It’s important to maintain a temperature of 77 degrees or cooler, and above freezing, so efficacy is highest when the product ...

While you may think of healthcare as only covering human health, animal and pet health is also a growing sector. Click to ...

The global veterinary biologics market is on a robust growth trajectory, with its valuation expected to reach USD 13,140.6 ...

Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term, sustainable perspective. More than 53,000 employees serve over 130 markets in the two business units Human Pharma ...

Bayer and Boehringer Ingelheim both had new data on their HER2-targeting small-molecule drugs to present at the World Conference on Lung Cancer (WCLC), hoping to add new oral therapies to the ...

The global Cattle & Porcine/Swine Reproductive Diseases market is expected to grow to USD 975.8 Million by 2029, up from USD ...

German drugmaker Boehringer Ingelheim has its first regulatory approval for spesolimab, its antibody therapy for rare and life-threatening skin disorder generalised pustular psoriasis (GPP), in ...

The Global Veterinary Antiseptic Market was valued at approximately USD 3.47 billion in 2023 and is anticipated to grow to at a compound annual growth rate (CAGR) of 7.2% during the forecast period ...

The global poultry diagnostics market is on the verge of remarkable expansion, with analysts forecasting a robust Compound Annual Growth Rate (CAGR) of 10.5% over the next decade. Valued at USD 590 ...

Denmark's Zealand Pharma and German partner Boehringer Ingelheim have won the U.S. Food ... The U.S. Food and Drug Administration has approved Elanco Animal Health's oral drug to protect dogs ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.